C
NexgenRx Inc. NXG.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Net Income 182.73% 90.51% 69.00% -8,256.67% -109.06%
Total Depreciation and Amortization -5.10% -4.68% -7.05% -10.44% -9.17%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -69.49% -70.48% -72.63% -72.84% 110.63%
Change in Net Operating Assets 25.79% 175.28% 71.49% 138.58% -171.12%
Cash from Operations 138.37% 51.01% 10.83% 14.01% -89.95%
Capital Expenditure -125.88% 64.23% 78.86% 81.49% 134.37%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -22.19% 20.66% -539.92% -38.89% 67.59%
Cash from Investing -482.20% 46.81% 33.49% 53.95% 105.77%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -25.13% 2.51% 44.90% 61.94% 70.43%
Issuance of Common Stock 200.00% -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -66.50% 5.83% -58.79% 4.60% 45.25%
Other Financing Activities -- -- -- -- --
Cash from Financing -44.87% 27.50% -10.10% 21.12% 56.56%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -97.58% 204.79% 204.63% 119.90% -103.39%
Weiss Ratings